No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.

Katalinic A, Noftz MR, Garcia-Velasco JA, Shulman LP, van den Anker JN, Strauss Iii JF

Open source

DOI
10.1093/hropen/hoae004
Published
2024
Container
Human reproduction open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/hropen/hoae004,
  title = {No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.},
  author = {Katalinic A and Noftz MR and Garcia-Velasco JA and Shulman LP and van den Anker JN and Strauss Iii JF},
  year = {2024},
  journal = {Human reproduction open},
  doi = {10.1093/hropen/hoae004},
  url = {https://doi.org/10.1093/hropen/hoae004}
}

RIS

TY  - JOUR
TI  - No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.
AU  - Katalinic A
AU  - Noftz MR
AU  - Garcia-Velasco JA
AU  - Shulman LP
AU  - van den Anker JN
AU  - Strauss Iii JF
PY  - 2024
JO  - Human reproduction open
DO  - 10.1093/hropen/hoae004
UR  - https://doi.org/10.1093/hropen/hoae004
ER  - 

APA

A, K., MR, N., JA, G., LP, S., JN, V. D. A., & JF, S. I. (2024). No additional risk of congenital anomalies after first-trimester dydrogesterone use: a systematic review and meta-analysis.. Human reproduction open. https://doi.org/10.1093/hropen/hoae004

Source records